← Leaderboards
Keping Xie
University Of Texas Md Anderson Can Ctr
$7,782,417
Attributed
$7,782,417
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,782,417 · 8
By mechanism
R01$7,511,373 · 7
R21$271,044 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Jasti S Rao$18,364,597
- Elizabeth A Grimm$11,275,665
- Paul J Chiao$8,649,694
- Ann M Killary$7,994,791
- Susan M Fischer$12,916,650
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMalignant Neoplasm Of PancreasMolecularPathway InteractionsTissuesGeneticEpigenetic ProcessDesignGrowthResourcesNeoplasm MetastasisSignal TransductionLeadInvestigationMalignant PhenotypeMediatingMolecular TargetOverexpressionClinically SignificantPathogenesisPancreasTranscription FactorProteinsPublic Health Relevance
Grant awards (28)
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$366,000
R01 · FY2016 · CA · contact PI
Integrated Signaling in Pancreatic Cancer Progression$366,000
R01 · FY2016 · CA · contact PI
Molecular Mediators of Pancreatic Cancer Invasion and Progression$332,000
R01 · FY2016 · CA · contact PI
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation$366,000
R01 · FY2015 · CA · contact PI
Molecular Mediators of Pancreatic Cancer Invasion and Progression$332,000
R01 · FY2015 · CA · contact PI
Molecular Mediators of Pancreatic Cancer Invasion and Progression$322,040
R01 · FY2014 · CA · contact PI
Functional Validation of Pancreatic Cancer Progression Biomarker$308,475
R01 · FY2014 · CA · contact PI
Genetic Approaches to Pancreatic Cancer Progression$246,779
R01 · FY2014 · CA · contact PI
Molecular Mediators of Pancreatic Cancer Invasion and Progression$332,000
R01 · FY2013 · CA · contact PI
Functional Validation of Pancreatic Cancer Progression Biomarker$298,934
R01 · FY2013 · CA · contact PI
Genetic Approaches to Pancreatic Cancer Progression$239,147
R01 · FY2013 · CA · contact PI
Functional Validation of Pancreatic Cancer Progression Biomarker$318,015
R01 · FY2012 · CA · contact PI
Genetic Approaches to Pancreatic Cancer Progression$254,412
R01 · FY2012 · CA · contact PI
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer$247,971
R01 · FY2012 · CA · contact PI
Functional Validation of Pancreatic Cancer Progression Biomarker$318,015
R01 · FY2011 · CA · contact PI
Genetic Approaches to Pancreatic Cancer Progression$254,412
R01 · FY2011 · CA · contact PI
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer$247,971
R01 · FY2011 · CA · contact PI
Functional Validation of Pancreatic Cancer Progression Biomarker$327,850
R01 · FY2010 · CA · contact PI
Genetic Approaches to Pancreatic Cancer Progression$262,280
R01 · FY2010 · CA · contact PI
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer$255,640
R01 · FY2010 · CA · contact PI
Molecular basis of pancreatic cancer progression and metastsis$135,522
R21 · FY2010 · CA · contact PI
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer$255,640
R01 · FY2009 · CA · contact PI
Molecular basis of pancreatic cancer progression and metastsis$135,522
R21 · FY2009 · CA · contact PI
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer$255,640
R01 · FY2008 · CA · contact PI
Antitumor Activity of Inducible Nitric Oxide Synthase$251,038
R01 · FY2005 · CA
Antitumor Activity of Inducible Nitric Oxide Synthase$251,038
R01 · FY2004 · CA
Antitumor Activity of Inducible Nitric Oxide Synthase$251,038
R01 · FY2003 · CA
Antitumor Activity of Inducible Nitric Oxide Synthase$251,038
R01 · FY2002 · CA